Carboplatin Labatec 150 mg/15 ml, solution pour perfusion

7680629020011 CH-62902 Infusionslösung
Carboplatin Labatec 150 mg/15 ml, solution pour perfusion
Carboplatin Labatec 150 mg/15 ml, solution pour perfusion
Carboplatin Labatec 150 mg/15 ml, solution pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/03/2024
Summary of Product Characteristics
Français
22/03/2024
Summary of Product Characteristics
Italien
22/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance HBESI

Reimbursement information

Public price
CHF 45.15
Specialties list
Yes
Generic
Yes
SL addition date: 01/04/2013

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
62902
Drug name
Carboplatin Labatec, solution pour perfusion
Galenic form
LSINF
ATC Code
L01XA02
Authorization status
Z
Dispensing category
A
First authorization
29/11/2012
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
CARBOPLATIN Labatec 150 mg/15ml flac 15 ml
Description (DE)
CARBOPLATIN Labatec 150 mg/15ml Durchstf 15 ml
Market launch
29/11/2012
Narcotic (BTM)
No

Original drug

Paraplatin, Infusionslösung
GTIN: 7680476710516
CHF 45.15
View original

Other package sizes (3)

CARBOPLATIN Labatec 450 mg/45ml flac 45 ml
1 DUR
GTIN: 7680629020028
View
CARBOPLATIN Labatec 600 mg/60ml flac 60 ml
1 DUR
GTIN: 7680629020035
View
CARBOPLATIN Labatec 50 mg/5ml flac 5 ml
1 DUR
GTIN: 7680629020042
View